Eyecelerator 2020

Virtual Conference | Friday, Nov. 6
8 a.m. - 4:30 p.m. PT

Attend the only innovation meeting that matters — now 100% online

CONFERENCE PROGRAM

Eyecelerator Overview

9:00 – 9:05 a.m. a.m.

David W. Parke II, MD, Steve Speares, Gil Kliman, MD, Vance Thompson, MD, Mark S. Blumenkranz MD

The 3C's: Impact of COVID, Capital Markets and Consolidation

8:05 – 9:05 a.m.

Top executive leads a sequence of multidisciplinary panel discussions that examine the key forces reshaping ophthalmic innovation. 

Moderator: Jim Mazzo
Panel 1:
Eric D. Donnenfeld, MD; Mark S. Humayun, MD, PhD; Jeffrey J. Kimbell, (Jeffrey J. Kimbell & Associates, Inc.); Jim Momtazee (Patient Square Capital)
 
Panel 2:
Larry Biegelsen (Wells Fargo); Mike Giaquinto (SVBLeerink); Gil Kliman, MD, (InterWest Partners); Elizabeth Yeu, MD

Innovations for Practice Recovery and Growth

9:05 – 10:05 a.m.

Rapidly accelerating advances in diagnostics, therapeutics, tele-health, patient flow.

Vance Thompson, MD; Ranya Habash, MD; Eduardo C. Alfonso, MD 

Mad Eye Money

10:05 – 10:28 a.m.

Strap in for a lightning round of market analysis and ideas for financing innovation.

Moderator: Gil Kliman, MD
 
Panelists: Jon Norris (Silicon Valley Bank); Brian Scullion (William Blair); Michael Lachman (EyeQ Research) 

Inside the Global Game, Pt. I

10:28 – 10:43 a.m.

The Academy's CEO sits down with executives from global health care giants to uncover key insights for advancing innovation partnerships. 

Moderator: David W. Parke II, MD
 

Strategic discussion with Johnson & Johnson Vision 

  • Warren Foust, Worldwide President, Surgical Vision

  • Raj Rajpal, MD, CMO, Global Head of Clinical and Medical Affairs

  • Xiao-YuSong, MD, PhD, Global Head of Research & Development

Company Showcase I: Anterior Segment/Glaucoma

10:43 a.m.– 12:17 p.m.

Moderators: Lama A. Al Aswad, MD and Ranya Habash, MD

➢ Presbyopia/Myopia

1. LensGen

2. Visus Therapeutics

3. Yolia Health

4. SightGlass Vision, Inc.

 

➢ Cornea/Dry Eye

1. Aperta Biosciences

2. TearClear

3. SilkTech Biopharmaceuticals

4. Trefoil Therapeutics

5. EyeYon Medical

 

➢ Drug Delivery

1. Emmecell

2. AnkyrBio, LLC

3. Kedalion Therapeutics

 

➢ Devices and Sensors

1. Centricity Vision, Inc.

2. PreVista

3. Infinite Medical Ventures

4. Implandata Ophthalmic Products GmbH

5. Injectsense, Inc.

Inside the Global Game, Pt. II

12:17 – 12:32 p.m.

The Academy's CEO sits down with executives from global health care giants to uncover key insights for advancing innovation partnerships. 

Moderator: David W. Parke II, MD
 

Strategic discussion with Alcon

  • Alan Landers, OD, MS, Head, Search & Evaluation BD&L Vision Care

  • Shannon Spock, Surgical Search and Evaluation Head, Business Development and Licensing

  • Costin Curatu, Head, Search and Evaluation, Surgical BD&L

Company Showcase II: Retina Secreted Factors, Genes, Devices

12:32 – 12:59 p.m.

Uncover key insights for advancing partnerships with industry giants.

Moderators: Mark Blumenkranz, MD and Allen Ho, MD

1. Neurotech Pharmaceuticals, Inc.

2. Aviceda Ophthalmics

3. Gensight Biologics

4. Notal Vision,Inc.

5. Pixium Vision

Opportunities & Challenges for Medium-Sized Companies

12:59 – 1:19 p.m.

Uncover key insights for advancing partnerships with industry giants.

Moderators: Allen Ho, MD and Sean Ianchulev, MD

Panelists: 

  • Wiley Chambers, MD (FDA)

  • Pravin Dugel, MD (Iveric Bio)

  • Rick Eiswirth (Alimera Sciences)

  • Cedric Francois, MD, PhD (Apellis)

  • Hylton Kalvaria (Verana Health)

  • Aaron Osborne (Adverum Biotech)

  • Ram Palanki (RegenxBio)

Company Showcase III: Advancing Trials in the Public Eye

1:19  – 1:46 p.m.

Moderators: Mark Blumenkranz, MD and Allen Ho, MD 

1. AldeyraTherapeutics, Inc.

2. Kubota Vision

3. Ocular Therapeutix

4. Lineage Cell Therapeutics, Inc.

5. Verana Health

Inside the Global Game, Pt. III

1:46  – 2:01 p.m.

The Academy's CEO sits down with executives from global health care giants to uncover key insights for advancing innovation partnerships. 

Strategic discussion with Allergan, an AbbVie company

  • Jag Dosanjh, Senior Vice President, Medical Therapeutics

  • Michael R. Robinson, MD, Vice President, Global Therapeutic Area Head Ophthalmology

  • Doug Faunce, PhD, Executive Director, Search and Evaluation-Eyecare Abbvie Corporate Strategy

Opportunities and Challenges for Large Companies

2:01  – 2:21 p.m.

Uncover key insights for advancing partnerships with industry giants.

Moderator: Mark Blumenkranz, MD

Panelists:

  • Abu Abraham, MD (Santen)

  • Anthony Adamis, MD (Genentech)

  • Eddy Anglade, MD (Johnson & Johnson Vision/Janssen)

  • Laurent Attias (Alcon)

  • Andrew Gitkin (Raymond James)

  • Chuck Hess (Bausch + Lomb)

  • Angelo Rago (Zeiss)

  • Dirk Sauer, PhD (Novartis)

  • Jonathan Weyne, MD (Regeneron) 

Inside the Global Game, Pt. IV

2:21 – 2:36 p.m.

The Academy's CEO sits down with executives from global health care giants to uncover key insights for advancing innovation partnerships. 

Moderator: David W. Parke II, MD

 

Strategic discussion with Zeiss

  • Euan S. Thomson, PhD, President 

  • Steve Schallhorn, MD, Chief Medical Officer 

  • Andy Chang, Head of Global Sales 

Rise of The Machines

2:36  – 3:36 p.m.

Robotics and brain-machine interfaces are still in their infancy but they have the potential to improve outcomes for ophthalmic patients by enabling digitally-driven therapies. Take a peek over the horizon at the emerging fields of robotics and brain machine interfaces with "the father of robotic surgery." 

Moderators: Ranya Habash, MD (BMI) and Gil Kliman, MD (Robotics)

 

Keynote – Fred Moll, MD
Chief Development Officer, Johnson & Johnson Medical Devices
Founder, Intuitive Surgical and Auris Health

 

Panelists: Dimitri Azar, MD, (Verily Life Sciences); Linda Lam MD, Associate Professor of Ophthalmology (USC Keck School of Medicine); Reza Zadno, CEO (Procept Biorobotics); Marc de Smet, MD, CMO (Preceyes); Doug Kelly, MD (FDA)

Cultivating Diversity in Innovation

3:36 – 4:21 p.m.

First-of-its-kind session explores the importance and measurable value of building a diverse community to advance new technology and treatments. 

Moderators: Lama A. Al-Aswad, MD, MPH and Deepinder K. Dhaliwal, MD, L.Ac

 

Keynote – The Mix That Matters: Innovation Through Diversity
Karin Schetelig, Principal, The Boston Consulting Group


Panelists: Caren Mason (STAAR Surgical); Jag Dosanjh (Allergan, an AbbVie company); Ramgopal Rao (LensGen, Inc.); Todd Pinkney (Centricity Vision)

Best of Show and Closing Remarks

4:21  – 4:30 p.m.

Eyecelerator Company Pick and and People's Choice Company Pick

Presented by Co-chairs Gil Kliman, MD, Mark Blumenkranz, MD, Vance Thompson, MD

2019_AAO_Herp_5304.jpg

Thanks to everyone who attended Eyecelerator 2020!

Despite the challenges of the last year, Eyecelerator exceeded expectations with more than 5000 ophthalmologists, entrepreneurs, investors and global business leaders in the ophthalmic innovation community enjoying...​

  • 40 cutting-edge company presentations

  • 14 hours of innovation-focused programming

  • Four widely attended live streams

  • One ground-breaking inaugural conference


​It's just the beginning.

12:17 – 12:32 p.m.

Inside the Global Game, Pt. II
Uncover key insights for advancing partnerships with industry giants.

Moderator: David W. Parke II, MD
 

Strategic discussion with Alcon

  • Alan Landers, OD, MS, Head, Search & Evaluation BD&L Vision Care

  • Shannon Spock, Surgical Search and Evaluation Head, Business Development and Licensing

  • Costin Curatu, Head, Search and Evaluation, Surgical BD&L

12:32 – 12:59 p.m.

Company Showcase II: Retina Secreted Factors, Genes,  Devices

Moderators: Mark Blumenkranz, MD and Allen Ho, MD

1. Neurotech Pharmaceuticals, Inc.

2. Aviceda Ophthalmics

3. Gensight Biologics

4. Notal Vision,Inc.

5. Pixium Vision